These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases. McKenzie JA; Spielman LJ; Pointer CB; Lowry JR; Bajwa E; Lee CW; Klegeris A Curr Aging Sci; 2017; 10(3):158-176. PubMed ID: 28302047 [TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation in Alzheimer's disease wanes with age. Hoozemans JJ; Rozemuller AJ; van Haastert ES; Eikelenboom P; van Gool WA J Neuroinflammation; 2011 Dec; 8():171. PubMed ID: 22152162 [TBL] [Abstract][Full Text] [Related]
9. T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers. Mietelska-Porowska A; Wojda U J Immunol Res; 2017; 2017():4626540. PubMed ID: 28293644 [TBL] [Abstract][Full Text] [Related]
10. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology. Martin E; Boucher C; Fontaine B; Delarasse C Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233 [TBL] [Abstract][Full Text] [Related]
11. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease. Clark LF; Kodadek T ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268 [TBL] [Abstract][Full Text] [Related]
12. Inflammation and Alzheimer's disease. Lee YJ; Han SB; Nam SY; Oh KW; Hong JT Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932 [TBL] [Abstract][Full Text] [Related]
13. Can We Treat Neuroinflammation in Alzheimer's Disease? Sánchez-Sarasúa S; Fernández-Pérez I; Espinosa-Fernández V; Sánchez-Pérez AM; Ledesma JC Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228179 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease. Grimm A; Friedland K; Eckert A Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143 [TBL] [Abstract][Full Text] [Related]
15. [Pro-inflammatory cytokines in Alzheimer's disease]. Stamouli EC; Politis AM Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090 [TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation in Alzheimer's disease: protector or promoter? Zilka N; Ferencik M; Hulin I Bratisl Lek Listy; 2006; 107(9-10):374-83. PubMed ID: 17262990 [TBL] [Abstract][Full Text] [Related]
17. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease. Wilcock DM; Hurban J; Helman AM; Sudduth TL; McCarty KL; Beckett TL; Ferrell JC; Murphy MP; Abner EL; Schmitt FA; Head E Neurobiol Aging; 2015 Sep; 36(9):2468-74. PubMed ID: 26103884 [TBL] [Abstract][Full Text] [Related]
18. Relationship between the hs-CRP as non-specific biomarker and Alzheimer's disease according to aging process. Song IU; Chung SW; Kim YD; Maeng LS Int J Med Sci; 2015; 12(8):613-7. PubMed ID: 26283879 [TBL] [Abstract][Full Text] [Related]
19. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. Cai Z; Hussain MD; Yan LJ Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978 [TBL] [Abstract][Full Text] [Related]
20. Peripheral immune system in aging and Alzheimer's disease. Cao W; Zheng H Mol Neurodegener; 2018 Oct; 13(1):51. PubMed ID: 30285785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]